• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名卵巢癌患者腹腔感染治疗期间出现耐亚胺培南铜绿假单胞菌。

Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma.

作者信息

Sze E H, Osborne N G, Adelson M D, Granato P

出版信息

J Natl Med Assoc. 1988 Oct;80(10):1133-5.

PMID:3150461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2625865/
Abstract

A 59-year-old woman was admitted to the hospital with ovarian carcinoma. After cytoreductive surgery, the patient developed intra-abdominal sepsis. After 17 days of intravenous imipenem, the patient's sputum culture grew imipenem-resistant Pseudomonas aeruginosa. On the 21st day of treatment with imipenem, her peritoneal culture also grew imipenem-resistant Pseudomonas aeruginosa.

摘要

一名59岁女性因卵巢癌入院。细胞减灭术后，该患者发生腹腔内感染。静脉输注亚胺培南17天后，患者痰培养出耐亚胺培南的铜绿假单胞菌。在使用亚胺培南治疗的第21天，其腹膜培养物也培养出耐亚胺培南的铜绿假单胞菌。

相似文献

1
Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma.一名卵巢癌患者腹腔感染治疗期间出现耐亚胺培南铜绿假单胞菌。
J Natl Med Assoc. 1988 Oct;80(10):1133-5.
2
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.铜绿假单胞菌分离株对亚胺培南的耐药性：感染的危险因素以及耐药性对临床和经济结局的影响。
Infect Control Hosp Epidemiol. 2006 Sep;27(9):893-900. doi: 10.1086/507274. Epub 2006 Aug 21.
3
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.厄他培南的使用对铜绿假单胞菌对亚胺培南敏感性的影响：一项医院病例研究。
Infect Control Hosp Epidemiol. 2009 May;30(5):487-90. doi: 10.1086/596781.
4
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.耐亚胺培南铜绿假单胞菌血流感染的临床影响
J Infect. 2009 Apr;58(4):285-90. doi: 10.1016/j.jinf.2009.02.010. Epub 2009 Mar 17.
5
Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.日本一家医院中耐亚胺培南铜绿假单胞菌手术感染的临床监测
J Hosp Infect. 2004 Feb;56(2):111-8. doi: 10.1016/j.jhin.2003.10.020.
6
Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns.耐亚胺培南铜绿假单胞菌：危险因素及抗生素敏感性模式
Clin Infect Dis. 1997 Nov;25(5):1094-8. doi: 10.1086/516092.
7
Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.铜绿假单胞菌在使用新型β-内酰胺类抗生素治疗期间对β-内酰胺类抗生素产生耐药性。
Chemioterapia. 1985 Feb;4(1):95-101.
8
[Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
Immun Infekt. 1986 Nov;14(6):224-6.
9
Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil.巴西一家教学医院收治的患者中，亚胺培南或头孢他啶耐药铜绿假单胞菌恢复的危险因素。
Infect Control Hosp Epidemiol. 2006 Sep;27(9):901-6. doi: 10.1086/507288. Epub 2006 Aug 21.
10
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Bratisl Lek Listy. 1996 Nov;97(11):647-51.

本文引用的文献

1
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.从嗜麦芽窄食单胞菌中分离出的诱导型青霉素β-内酰胺酶的纯化及特性
Antimicrob Agents Chemother. 1982 Oct;22(4):564-70. doi: 10.1128/AAC.22.4.564.
2
In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin.耐甲氧西林和甲氧西林敏感金黄色葡萄球菌菌株对N-甲酰亚胺基硫霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Nov;22(5):906-8. doi: 10.1128/AAC.22.5.906.
3
Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.铜绿假单胞菌的外膜通透性：野生型与抗生素超敏突变体的比较。
Antimicrob Agents Chemother. 1982 Feb;21(2):299-309. doi: 10.1128/AAC.21.2.299.
4
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.亚胺培南治疗铜绿假单胞菌及其他严重细菌感染。
Antimicrob Agents Chemother. 1984 Nov;26(5):673-7. doi: 10.1128/AAC.26.5.673.
5
Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin.铜绿假单胞菌染色体β-内酰胺酶调控改变的突变体对哌拉西林、头孢他啶和头孢磺啶的耐药性。
Antimicrob Agents Chemother. 1984 Mar;25(3):382-4. doi: 10.1128/AAC.25.3.382.
6
Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.
Lancet. 1984 Apr 21;1(8382):868-71.
7
Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.亚胺培南/西司他丁治疗囊性纤维化患者多重耐药铜绿假单胞菌肺部感染
J Antimicrob Chemother. 1985 Nov;16(5):629-35. doi: 10.1093/jac/16.5.629.
8
Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S513-7. doi: 10.1093/clinids/7.supplement_3.s513.
9
Mutation of Pseudomonas aeruginosa to piperacillin resistance mediated by beta-lactamase production.
J Antimicrob Chemother. 1985 Jun;15(6):665-70. doi: 10.1093/jac/15.6.665.
10
Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.
J Antimicrob Chemother. 1985 Oct;16(4):499-507. doi: 10.1093/jac/16.4.499.